Metabolomic Variations in the Saxagliptin-Treated Type 2 Diabetes Mellitus Patients

Summary

This study is an open-label, cohort study to evaluate the potential mechanisms of Saxagliptin in the treatment of patients with type 2 diabetes (T2DM) using a comprehensive metabolomic method, in combination with fingerprint analysis and target analysis. It is a sub-study of STUDY: D168L00008.

Timeline

Start

2012-10

Primary completion

2016-12

Completion

2017-12

Drugs

Indications